Analytical and Bioanalytical Chemistry 2011-01-01

A label-free sensing method for phosphopeptides using two-layer gold nanoparticle-based localized surface plasma resonance spectroscopy.

Jen-Yi Chen, Yu-Chie Chen

Index: Anal. Bioanal. Chem 399(3) , 1173-80, (2011)

Full Text: HTML

Abstract

In this study, a new type of localized surface plasmon resonance (LSPR) sensing substrate for phosphopeptides was explored. It has been known that LSPR response for target species is larger in the near-infrared region (NIR) than in the visible region of the electromagnetic spectrum. Several types of noble metal nanoparticles (NPs) with NIR absorption capacities have been previously demonstrated as effective LSPR-sensing nanoprobes. Herein, we demonstrate a straightforward approach with improved sensitivity by simply using layer-by-layer (LBL) spherical Au NPs self-assembled on glass slides as the LSPR-sensing substrates that are responsive in the NIR region of the electromagnetic spectrum. The modified glass slide acquired an LSPR absorption band in the NIR, which resulted from the dipole-dipole interactions between Au NPs. To enable the chip to sense phosphopeptides, the surface of the glass chip was spin-coated with thin titania film (TiO(2)-Glass@Au NPs). Absorption spectrophotometry was employed as a detection tool. Tryptic digest of α-casein was used as a model sample. The feasibility of using the new LSPR approach for detecting a potential risk factor leading to cancers (i.e., phosphorylated fibrinopeptide A) directly from human serum samples was demonstrated. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) was used to confirm the results.


Related Compounds

Related Articles:

Thromboprophylaxis in patients receiving chemotherapy.

2012-05-10

[N. Engl. J. Med. 366(19) , 1839; author reply 1839-40, (2012)]

Routine heparin for patients with cancer? One answer, more questions.

2012-02-16

[N. Engl. J. Med. 366(7) , 661-2, (2012)]

Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy.

2011-03-01

[Thromb. Res. 127(3) , 277-8, (2011)]

Thrombogenicity of a new injectable biocompatible elastomer for aneurysm exclusion, compared to expanded polytetrafluoroethylene in a human ex vivo model.

2012-06-01

[Eur. J. Vasc. Endovasc. Surg. 43(6) , 675-80, (2012)]

Novel aspects of fibrin(ogen) fragments during inflammation.

2011-01-01

[Mol. Med. 17(5-6) , 568-73, (2011)]

More Articles...